Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Complete Remission of Bone Metastases in Renal Cell Carcinoma With Nivolumab

Cureus
2019English

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Clinical Genitourinary Cancer
OncologyUrology
2017English

Brain Complete Response to Cabozantinib Prior to Radiation Therapy in Metastatic Renal Cell Carcinoma

Case Reports in Urology
2019English

Complete Pathologic Response After Chemoradiotherapy in a Patient With Rectal Squamous Cell Carcinoma: A Case Report

Cancer Biology and Medicine
Cancer ResearchOncology
2017English

Metastatic Renal Cell Carcinoma With Level IV Thrombus: Contemporary Management With Complete Response to Neoadjuvant Targeted Therapy

Case Reports in Urology
2019English

Single Case of a Complete Response in a Metastatic Urothelial Carcinoma Patient Treated With Zoptarelin Doxorubicin

European Oncology and Haematology
OncologyHematology
2014English

Clinical Outcome of Third-Line Pazopanib in a Patient With Metastatic Renal Cell Carcinoma

Case Reports in Oncological Medicine
Oncology
2015English

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy